Background. Inhaled anaesthetics (IAs) produce multiple dose-dependent behavioural effects including amnesia, hypnosis, and immobility in response to painful stimuli that are mediated by distinct anatomical, cellular, and molecular mechanisms. Amnesia is produced at lower anaesthetic concentrations compared with hypnosis or immobility. Nicotinic acetylcholine receptors (nAChRs) modulate hippocampal neural network correlates of memory and are highly sensitive to IAs. Activation of hippocampal nAChRs stimulates the release of norepinephrine (NE), a neurotransmitter implicated in modulating hippocampal synaptic plasticity. We tested the hypothesis that IAs disrupt hippocampal synaptic mechanisms critical to memory by determining the effects of isoflurane on NE release from hippocampal nerve terminals.
General anaesthesia is a complex behavioural response to a number of chemically and pharmacologically diverse drugs, which is characterized by dose-, region-, and mechanism-specific endpoints.
1 Amnesia occurs at low (subanaesthetic) concentrations, and immobility requires relatively higher concentrations of halogenated inhaled (volatile) anaesthetics (IAs), which supports the involvement of distinct neurophysiological mechanisms with different anaesthetic sensitivities. 2 Whether amnesia and immobility result from graded effects on the same molecular/cellular target(s) or from separate targets with distinct anaesthetic sensitivities is unclear. The immobilizing effect has been localized to spinal networks, although the precise molecular and cellular mechanisms remain unknown. 3 In contrast, amnesia involves forebrain structures such as amygdala and hippocampus, which are central to memory acquisition and consolidation. 4 Changes in synaptic efficacy such as hippocampal longterm potentiation or depression are neuronal network correlates of memory that are modulated by both norepinephrine (NE) 5 6 and nicotinic acetylcholine receptors (nAChRs). 7 The nerve terminal is a potential site of action for anaesthetic effects on synaptic transmission. 8 Selective inhibition of depolarization-evoked release of excitatory glutamate vs release of inhibitory GABA from neocortical nerve terminals by clinically relevant concentrations of IAs supports an overall depression of excitatory transmission during anaesthesia. 9 10 Acetylcholine and NE are excitatory neurotransmitters implicated in memory mechanisms. 11 Moreover, hippocampal activation of nAChRs stimulates NE release 12 and facilitates long-term potentiation. 13 As heterologously expressed neuronal nAChRs are highly sensitive to IAs at subanaesthetic concentrations, 14 15 we determined the effects of isoflurane on NE release as a potential neurochemical model for the amnesic effects of IAs. We hypothesized that nAChRevoked NE release from isolated hippocampal nerve terminals would be more sensitive to inhibition by IAs than depolarization-evoked release if involved in anaestheticinduced amnesia.
Methods
All drugs were obtained from Sigma-Aldrich Chemical Co. (St Louis, MO, USA) unless otherwise indicated. Isolated nerve terminals (synaptosomes) were prepared from adult male Sprague-Dawley rats (200-280 g, n¼42) as described previously 10 under National Institutes of Health guidelines as approved by the Weill Cornell Medical College IACUC. Briefly, brains were rapidly removed from rats anaesthetized with 80% CO 2 /20% O 2 , the hippocampus was removed and homogenized in ice-cold 0.32 M sucrose with a motor-driven (500 rpm) Teflon-glass homogenizer, the homogenate was centrifuged for 2 min at 4000 g, and the resulting supernatant was centrifuged through a sucrose gradient to demyelinate and pellet the isolated hippocampal nerve terminals. Synaptosomes were radiolabelled with 20 nM [ PerkinElmer, Boston, MA, USA), collected by centrifugation for 10 min at 20 000 g at 48C, loaded into release chambers, and superfused at 378C with KHB using a modified Brandel SF-12 apparatus. 10 Release was evoked by 2 min pulses of 100 mM (-) nicotine or 5 mM 4-aminopyridine (4AP) in the presence of varying concentrations of isoflurane, nAChR antagonists, or the Na þ channel antagonist tetrodotoxin (TTX), all applied 12 min before the release stimulus. Radioactivity in 1 min fractions was determined by liquid scintillation spectrometry using BioSafe II scintillation cocktail (RPI, Mt Prospect, IL, USA) with quench correction (Beckman-Coulter, Fullerton, CA, USA).
Isoflurane concentrations were sampled and quantified by gas chromatography as described. 10 Release was quantified as summed fractional release above baseline (sum DFR), normalized to the mean of all assay controls, and analysed using ANOVA or the Student t-test. Concentration -effect data were fitted to sigmoidal curves using Prism version 5.0a (GraphPad, San Diego, CA, USA). Significant differences between IC 50 values were determined by F-test comparison of best-fit values derived from independent curve fits.
Results
Stimulation of superfused rat hippocampal nerve terminals with a maximally effective concentration of nicotine (Fig. 1A) , a non-selective nAChR agonist, 13 selectively evoked NE release compared with GABA or glutamate release (Fig. 1B) . In contrast, depolarization by 4AP, a K þ channel blocker that mimics repetitive action-potentialmediated depolarization, 16 evoked significant release of NE, GABA, and glutamate (Fig. 1B) . Comparable fractions of NE release were evoked by either 100 mM nicotine or 5 mM 4AP (Fig. 1B ), which were 10-fold less than the fraction evoked by 1 mM 4AP, a near maximally effective concentration that is routinely used for in vitro studies of transmitter release (data not shown). Labelling of dopaminergic nerve terminals with [
H]NE
17 was prevented by including GBR12935, a selective dopamine transporter blocker, during the radiolabelling procedure. Specific labelling of noradrenergic terminals was confirmed by the failure of dihyro-b-erythroidine (DHbE) to inhibit NE release (Fig. 1C) , as DHbE potently inhibits nicotineevoked dopamine release. 12 Nicotine-evoked NE release was dependent on extracellular Ca 2þ and was completely blocked by the nonselective nAChR antagonist mecamylamine (Fig. 1C) . Release was insensitive to the heteromeric b2-subunitpreferring nAChR antagonist DHbE, 18 partially blocked by the homomeric a7 nAChR antagonist methyllycaconitine (MLA), 19 and partially blocked by the selective voltage-gated Na þ channel blocker TTX (Fig. 1C) . Nicotine-evoked NE release was inhibited by isoflurane; release returned to control levels after 12 min of isoflurane-free perfusion (which reduced isoflurane concentrations to undetectable levels; Fig. 2A ). The singledrug and two-drug combination data were compared by the Student t-test after F-test determination of matching standard deviations. Maximal inhibition of nicotine-evoked NE release by isoflurane (achieved with 0.7 mM) was unaffected by the addition of DHbE, but was significantly increased by the addition of MLA or TTX ( Fig. 2A) . Combined MLA and TTX did not increase inhibition compared with either TTX or MLA alone.
Inhibition of nicotine-or 4AP-evoked NE release by isoflurane was concentration-dependent (Fig. 2B) . Nicotine-evoked NE release was significantly more sensitive (P¼0.02) to inhibition by isoflurane [IC 50 ¼0.18 (SD 0.02) mM] than was 4AP-evoked NE release [IC 50 ¼0.27 (0.03) mM; Fig. 2B ]. Significant inhibition occurred at subanaesthetic isoflurane concentrations [35 (9) % at 0.18 mM, P¼0.002] based on its minimum alveolar concentration (MAC) for immobilization in response to a noxious stimulus in rats (0.35 mM). 20 Isoflurane at concentrations .0.4 mM produced sustained increases in basal NE release (Fig. 2B , inset), as described previously for halothane. 21 
Discussion
Nerve terminals are potential sites of IA effects on synaptic transmission. 8 -10 nAChRs are ligand-gated ion channels that can modulate transmitter release by mediating presynaptic Na þ and Ca 2þ entry. 22 Some subtypes of nAChRs are potently blocked by IAs, 14 15 23 but the possible role of this mechanism in presynaptic anaesthetic effects had not been determined. We tested the hypothesis that the IA isoflurane selectively inhibits nAChR-evoked vs depolarization-evoked NE release. Isoflurane inhibited nicotine-evoked NA release from isolated rat hippocampal nerve terminals at significantly lower concentrations compared with NE release evoked by the non-selective depolarizing agent 4AP. This suggests that isoflurane inhibits nicotine-evoked NE release by a distinct mechanism from that involved in its inhibition of generalized depolarization-evoked release. This differential sensitivity of nAChR-vs depolarization-evoked release to inhibition by isoflurane correlates with the lower doses of isoflurane required for amnesia vs immobility in vivo, such that these synaptic effects could be relevant mechanisms for distinct dose-dependent end-points of isoflurane anaesthesia.
Pentameric nAChRs comprise multiple subunit isoforms (a2-10 and b2 -4), but most nAChRs in the central nervous system are composed of heteromeric a4b2 or homomeric a7 subunits, both of which appear to be critical for memory function. 24 The a3b4 subtype is predominantly peripheral, but is also found in adult rat hippocampus 25 where it contributes to nicotine-evoked NE release from rat hippocampal synaptosomes. 26 27 The a4b2 and a3b4 nAChR subtypes selectively gate Na þ , whereas a7 nAChRs have a higher ratio of Ca 2þ to Na þ permeability. 13 Use of selective receptor blockers showed that 43% of nicotine-evoked NE release was mediated by MLA-sensitive a7-subunit-containing nAChRs, whereas DHbE-sensitive heteromeric nAChRs were not involved. Although selective inhibitors of b4-containing nAChRs are unavailable, the use of selective a-conotoxins suggests that non-a7-dependent NE release in hippocampus is probably mediated by a3b4 nAChRs. 26 27 NE release evoked by nicotine via nAChR activation was compared with NE release evoked by 4AP, a secretegogue that indirectly activates presynaptic Na þ channels and mimics action potential stimulation of neurotransmitter release. 9 16 Nicotine evoked NE release, but not glutamate or GABA release, consistent with selective localization of nAChRs on noradrenergic terminals. Voltage-gated Na þ channel block by TTX, which prevents were performed by one-way ANOVA (*P,0.05; **P,0.01; ***P,0.001 vs control). (C) Nicotine-evoked NE release (n¼61) required extracellular Ca 2þ (n¼8) and was nAChR-dependent as indicated by inhibition by the non-selective nAChR blocker mecamylamine (Mec, 10 mM, n¼5). Release was not inhibited by the selective b2 antagonist DHbE (30 mM, n¼5) and was partially inhibited by the selective a7 antagonist MLA (10 mM, n¼8) or the Na þ channel blocker TTX (1 mM, n¼12). Statistical comparison of sum DFR values [mean (SEM)] with control was performed by one-way ANOVA (**P,0.01; ***P,0.001).
Nicotinic receptor-evoked hippocampal NE release depolarization-dependent activation of downstream voltage-gated Ca 2þ channels, partially inhibited nicotineevoked NE release. This suggests that nAChR activation can trigger downstream Na þ channel activation to produce further depolarization and Ca 2þ -dependent NE release. Presynaptic nAChR effects are region-specific, as nicotinic receptor agonists evoke excitatory amino acid release from rat prefrontal cortex 28 and GABA release from mouse whole-brain 29 synaptosomes. In addition to differences in nAChR-subtype distribution between brain regions, 30 31 differences in nAChR-subtypes exist between the same brain region of different species. 27 32 Identification of the specific nAChR subtypes involved in regulating hippocampal NE release and their individual anaesthetic sensitivities will require more selective nAChR-subtype ligands and/or targeted genetic deletion studies.
Hippocampal long-term potentiation, a form of synaptic plasticity that is widely studied as a cellular correlate of memory, 33 is modulated by both norepinephrine 34 and nAChRs. 24 Neuronal nAChR-mediated NE release in hippocampus plays a critical role in memory formation 35 and is a likely site of anaesthetic-induced amnesia.
1 Neuronal nAChRs are sensitive to IAs at subanaesthetic concentrations that are sufficient to produce amnesia 23 but insufficient for immobilization in response to a painful stimulus as defined by the MAC. 2 36 Our observations that isoflurane at subanaesthetic concentrations inhibits nAChR-dependent release of NE from rat hippocampal nerve terminals are consistent with the ability of IAs to disrupt hippocampal memory mechanisms. 37 Inhibition of NE release evoked by 4AP-induced depolarization required higher isoflurane concentrations comparable with those that inhibit 4AP-evoked glutamate release from rat 9 and mouse 38 cortical nerve terminals. These less potent effects of isoflurane on depolarization-evoked transmitter release involve effects on presynaptic voltage-gated Na þ channels, 39 Ca 2þ channels, 40 and/or TREK-1 channels. 41 Taken together, these findings indicate that both ligand-gated and voltage-gated ion channels are presynaptic targets for dose-dependent transmitter-selective effects of IAs on transmitter release from mammalian nerve terminals.
Isoflurane inhibited nAChR-mediated NE release by up to 77% (but this maximal effect is probably limited by the stimulatory effect of isoflurane on basal NE release), implicating effects on both heteromeric and a7-subunit-containing receptors. The a7-subunit-selective blocker MLA produced 67% inhibition of nicotine-evoked NE release. Both TTX-and MLA-insensitive nicotine-evoked NE release were fully inhibited by isoflurane, demonstrating IA effects on targets in addition to voltage-gated Na þ channels and a7-containing nAChRs, probably including heteromeric nAChR subtypes such as a3b4 as discussed earlier. This 37 Only nicotine-evoked NE was significantly inhibited by less than clinical concentrations of isoflurane (F-test comparison with 100%, **P,0.01). Significant increases in basal NE release by isoflurane alone were evident only at concentrations .0.4 mM (1 MAC; inset). Data are presented as mean (SEM).
conclusion is further supported by the incomplete block of nicotine-evoked NE release by the combination of TTX and MLA. Recently, inhibition of nicotine-evoked NE release from spinal cord slices has also been shown to involve a7 nAChRs, and not b2-subunit containing nAChRs. 23 Earlier studies had suggested that a7 nAChRs were resistant to isoflurane, 14 but subsequent studies indicated that both a7 and non-a7-subunit containing nAChRs are indeed inhibited by isoflurane. 23 42 In summary, isoflurane inhibited nAChR-dependent NE release from isolated rat hippocampal nerve terminals at subanaesthetic concentrations in the range of its amnesic effects. This correlates with the greater sensitivity to inhibition by IAs of nAChR-dependent NE release compared with depolarization-evoked transmitter release. These findings are consistent with distinct presynaptic mechanisms for anaesthetic-induced amnesia, involving nAChR inhibition, and for immobility, involving the inhibition of Na þ channels and for possibly other targets at higher doses. Presynaptic anaesthetic mechanisms include concentrationdependent inhibition of both ligand-gated and voltagegated ion channels coupled to neurotransmitter-selective inhibition of transmitter release.
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